Search Results

There are 116140 results for: content related to: Treatment should not be initiated too soon in Parkinson's disease

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  4. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  5. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

    Journal of Pineal Research

    Volume 40, Issue 3, April 2006, Pages: 204–213, Gaia Rocchitta, Rossana Migheli, Giovanni Esposito, Bianca Marchetti, Maria S. Desole, Egidio Miele and Pier Andrea Serra

    Version of Record online : 5 DEC 2005, DOI: 10.1111/j.1600-079X.2005.00299.x

  6. You have free access to this content
    Unpredictable Rotational Responses to L-dopa in the Rat Model of Parkinson’s Disease: the Role of L-dopa Pharmacokinetics and Striatal Dopamine Depletion

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 2, February 2012, Pages: 162–170, Tiina M. Kääriäinen, Mikko Käenmäki, Markus M. Forsberg, Niko Oinas, Anne Tammimäki and Pekka T. Männistö

    Version of Record online : 13 SEP 2011, DOI: 10.1111/j.1742-7843.2011.00782.x

  7. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  8. Limitations of current Parkinson's disease therapy

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S3–S15, Olivier Rascol, Pierre Payoux, Fabienne Ory, Joaquim J. Ferreira, Christine Brefel-Courbon and Jean-Louis Montastruc

    Version of Record online : 24 MAR 2003, DOI: 10.1002/ana.10513

  9. Levodopa: Effect on cell death and the natural history of Parkinson's disease

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 37–44, C. Warren Olanow

    Version of Record online : 11 DEC 2014, DOI: 10.1002/mds.26119

  10. You have free access to this content
    Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia

    Journal of Neurochemistry

    Volume 118, Issue 1, July 2011, Pages: 12–23, Nina Nevalainen, Sara af Bjerkén, Martin Lundblad, Greg A. Gerhardt and Ingrid Strömberg

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1471-4159.2011.07292.x

  11. Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats

    Journal of Neuroscience Research

    Volume 72, Issue 6, 15 June 2003, Pages: 768–780, Justin D. Oh, Karnon Chartisathian, Syed M. Ahmed and Thomas N. Chase

    Version of Record online : 25 APR 2003, DOI: 10.1002/jnr.10629

  12. Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates

    Movement Disorders

    Volume 20, Issue 3, March 2005, Pages: 306–314, Lance A. Smith, Michael J. Jackson, Ghassan Al-Barghouthy, Sarah Rose, Mikko Kuoppamaki, Warren Olanow and Peter Jenner

    Version of Record online : 15 OCT 2004, DOI: 10.1002/mds.20317

  13. Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure

    Movement Disorders

    Volume 18, Issue 5, May 2003, Pages: 487–495, Lance A. Smith, Michael J. Jackson, Matthew J. Hansard, Eleni Maratos and Peter Jenner

    Version of Record online : 28 MAR 2003, DOI: 10.1002/mds.10394

  14. Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent, regionally selective bimodal effects on striatal dopamine kinetics in vivo

    Journal of Neurochemistry

    Volume 136, Issue 6, March 2016, Pages: 1270–1283, Rashed Harun, Kristin M. Hare, Elizabeth M. Brough, Miranda J. Munoz, Christine M. Grassi, Gonzalo E. Torres, Anthony A. Grace and Amy K. Wagner

    Version of Record online : 13 JAN 2016, DOI: 10.1111/jnc.13444

  15. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 631–641, Eleni C. Maratos, Michael J. Jackson, Ronald K. B. Pearce and Peter Jenner

    Version of Record online : 11 JUL 2001, DOI: 10.1002/mds.1149

  16. You have free access to this content
    l-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells

    Journal of Neurochemistry

    Volume 78, Issue 3, August 2001, Pages: 535–545, E. Rodríguez-Martín, S. Canals, M. J. Casarejos, S. de Bernardo, A. Handler and M. A. Mena

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00440.x

  17. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 19–36, Andrew J. Lees, Eduardo Tolosa and C. Warren Olanow

    Version of Record online : 8 DEC 2014, DOI: 10.1002/mds.26120

  18. The medical treatment of Parkinson disease from James Parkinson to George Cotzias

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 4–18, Stanley Fahn

    Version of Record online : 9 DEC 2014, DOI: 10.1002/mds.26102

  19. Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Version of Record online : 21 OCT 2014, DOI: 10.1002/mds.26050

  20. You have free access to this content
    Serotonergic modulation of receptor occupancy in rats treated with l-DOPA after unilateral 6-OHDA lesioning

    Journal of Neurochemistry

    Volume 120, Issue 5, March 2012, Pages: 806–817, Adjmal Nahimi, Mette Høltzermann, Anne M. Landau, Mette Simonsen, Steen Jakobsen, Aage Kristian Olsen Alstrup, Kim Vang, Arne Møller, Gregers Wegener, Albert Gjedde and Doris J. Doudet

    Version of Record online : 23 JAN 2012, DOI: 10.1111/j.1471-4159.2011.07598.x